Generation of donor organs in chimeric animals via blastocyst complementation

The lack of organs for transplantation is an important problem in medicine today. The growth of organs in chimeric animals may be the solution of this. The proposed technology is the interspecific blastocyst complementation method in combination with genomic editing for obtaining “free niches” and p...

Full description

Saved in:
Bibliographic Details
Main Authors: T. I. Babochkina, L. A. Gerlinskaya, M. P. Moshkin
Format: Article
Language:English
Published: Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2020-12-01
Series:Вавиловский журнал генетики и селекции
Subjects:
Online Access:https://vavilov.elpub.ru/jour/article/view/2852
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575072278151168
author T. I. Babochkina
L. A. Gerlinskaya
M. P. Moshkin
author_facet T. I. Babochkina
L. A. Gerlinskaya
M. P. Moshkin
author_sort T. I. Babochkina
collection DOAJ
description The lack of organs for transplantation is an important problem in medicine today. The growth of organs in chimeric animals may be the solution of this. The proposed technology is the interspecific blastocyst complementation method in combination with genomic editing for obtaining “free niches” and pluripotent stem cell production methods. The CRISPR/Cas9 method allows the so-called “free niches” to be obtained for blastocyst complementation. The technologies of producing induced pluripotent stem cells give us the opportunity to obtain human donor cells capable of populating a “free niche”. Taken together, these technologies allow interspecific blastocyst complementation between humans and other animals, which makes it possible in the future to grow human organs for transplantations inside chimeric animals. However, in practice, in order to achieve successful interspecific blastocyst complementation, it is necessary to solve a number of problems: to improve methods for producing “chimeric competent” cells, to overcome specific interspecific barriers, to select compatible cell developmental stages for injection and the corresponding developmental stage of the host embryo, to prevent apoptosis of donor cells and to achieve effective proliferation of the human donor cells in the host animal. Also, it is very important to analyze the ethical aspects related to developing technologies of chimeric organisms with the participation of human cells. Today, many researchers are trying to solve these problems and also to establish new approaches in the creation of interspecific chimeric organisms in order to grow human organs for transplantation. In the present review we described the historical stages of the development of the blastocyst complementation method, examined in detail the technologies that underlie modern blastocyst complementation, and analyzed current progress that gives us the possibility to grow human organs in chimeric animals. We also considered the barriers and issues preventing the successful implementation of interspecific blastocyst complementation in practice, and discussed the further development of this method.
format Article
id doaj-art-2d2f95f16d8149de84b9893073758f2b
institution Kabale University
issn 2500-3259
language English
publishDate 2020-12-01
publisher Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
record_format Article
series Вавиловский журнал генетики и селекции
spelling doaj-art-2d2f95f16d8149de84b9893073758f2b2025-02-01T09:58:09ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592020-12-0124891392110.18699/VJ20.6901122Generation of donor organs in chimeric animals via blastocyst complementationT. I. Babochkina0L. A. Gerlinskaya1M. P. Moshkin2Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of SciencesInstitute of Cytology and Genetics of Siberian Branch of the Russian Academy of SciencesInstitute of Cytology and Genetics of Siberian Branch of the Russian Academy of SciencesThe lack of organs for transplantation is an important problem in medicine today. The growth of organs in chimeric animals may be the solution of this. The proposed technology is the interspecific blastocyst complementation method in combination with genomic editing for obtaining “free niches” and pluripotent stem cell production methods. The CRISPR/Cas9 method allows the so-called “free niches” to be obtained for blastocyst complementation. The technologies of producing induced pluripotent stem cells give us the opportunity to obtain human donor cells capable of populating a “free niche”. Taken together, these technologies allow interspecific blastocyst complementation between humans and other animals, which makes it possible in the future to grow human organs for transplantations inside chimeric animals. However, in practice, in order to achieve successful interspecific blastocyst complementation, it is necessary to solve a number of problems: to improve methods for producing “chimeric competent” cells, to overcome specific interspecific barriers, to select compatible cell developmental stages for injection and the corresponding developmental stage of the host embryo, to prevent apoptosis of donor cells and to achieve effective proliferation of the human donor cells in the host animal. Also, it is very important to analyze the ethical aspects related to developing technologies of chimeric organisms with the participation of human cells. Today, many researchers are trying to solve these problems and also to establish new approaches in the creation of interspecific chimeric organisms in order to grow human organs for transplantation. In the present review we described the historical stages of the development of the blastocyst complementation method, examined in detail the technologies that underlie modern blastocyst complementation, and analyzed current progress that gives us the possibility to grow human organs in chimeric animals. We also considered the barriers and issues preventing the successful implementation of interspecific blastocyst complementation in practice, and discussed the further development of this method.https://vavilov.elpub.ru/jour/article/view/2852chimerisminterspecies chimeraembryo scipsccrispr/cas9organ generation
spellingShingle T. I. Babochkina
L. A. Gerlinskaya
M. P. Moshkin
Generation of donor organs in chimeric animals via blastocyst complementation
Вавиловский журнал генетики и селекции
chimerism
interspecies chimera
embryo sc
ipsc
crispr/cas9
organ generation
title Generation of donor organs in chimeric animals via blastocyst complementation
title_full Generation of donor organs in chimeric animals via blastocyst complementation
title_fullStr Generation of donor organs in chimeric animals via blastocyst complementation
title_full_unstemmed Generation of donor organs in chimeric animals via blastocyst complementation
title_short Generation of donor organs in chimeric animals via blastocyst complementation
title_sort generation of donor organs in chimeric animals via blastocyst complementation
topic chimerism
interspecies chimera
embryo sc
ipsc
crispr/cas9
organ generation
url https://vavilov.elpub.ru/jour/article/view/2852
work_keys_str_mv AT tibabochkina generationofdonororgansinchimericanimalsviablastocystcomplementation
AT lagerlinskaya generationofdonororgansinchimericanimalsviablastocystcomplementation
AT mpmoshkin generationofdonororgansinchimericanimalsviablastocystcomplementation